Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medius Holdings Co., Ltd. (3154.T)
Tokyo, JP
Medius Holdings Co., Ltd. is a Japanese enterprise deeply embedded in the healthcare sector. The company's operations involve the distribution of a diverse range of medical devices, encompassing fundamental consumables such as syringes and gauze, as well as sophisticated medical systems. In addition to sales, it offers essential repair, after-sales assistance, and maintenance services for this equipment to hospitals and various other medical institutions. Medius Holdings also engages in the provision, through sale and rental, of nursing care and welfare equipment, catering to hospitals, nursing facilities, and private individuals. Moreover, the firm supplies critical emergency response items, including specialized medical instruments for ambulances, automated external defibrillators (AEDs), and other vital emergency provisions that address significant societal needs. Founded in 2009 and based in Tokyo, Japan, the company was formerly known as Kyowa Medical Holdings, Inc. before rebranding to Medius Holdings Co., Ltd. in October 2010.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.47% | +2.79% | +2.54% | +0.95% | +5.74% | +4.05% | -11.95% | +1.32% | -11.86% | +119.90% | +481.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+11.1% ★ Q1'26: +2.2% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+21.3% ★ Q1'26: -7.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+0.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+0.9% Q1'26: +1.7% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+5.5% Q1'26: +10.8% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.8% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×4.59× Q1'26: 3.13× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2017 actual |
|---|---|
| Revenue |
162.65B
est: 166.00B (-2.0%)
|
| EBITDA |
2.26B
est: 2.76B (-18.3%)
|
| EBIT |
1.49B
est: 1.75B (-14.9%)
|
| Net Income |
863.22M
est: 1.03B (-16.1%)
|
| SGA |
1.36B
est: 17.57B (-92.3%)
|
| EPS |
44.37
est: 46.27 (-4.1%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 15.7K | 0.45% |
| 2 | iShares Core TOPIX ETF 1475.T | 0.00% | 134.8K | 0.05% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 62.0K | 0.28% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 67.8K | 0.22% |
| 5 | Dimensional - International Small Cap ETF DFIS | 0.00% | 9.9K | 0.39% |
| 6 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hiroto Takei | Manager of Presidential Division & Director | — | male |
| Hiroyuki Akutagawa | Senior Managing Executive Officer, GM of Corporate Management Headquarters & Director | — | male |
| Masaru Kuribara | Senior Managing Executive Officer and Director | — | male |
| Satoru Umesawa | Senior Managing Executive Officer and Director | — | male |
| Shuhei Miyaji | Senior Managing Executive Officer & GM of Presidential Division & Director | — | male |
| Yasuhiko Ikeya | Chief Executive Officer, President & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3154.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
